Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancer

1 Oct 2012

Abstract excerpt

Dear Editor, Lung cancer—predominantly non-small cell lung cancer (NSCLC)—is the most prevalent cancer in the world, in terms of both incidence and mortality. Squamous cell lung cancer (SCLC) is the second most common type of NSCLC, making up about 30% of all cases. The average 5-year survival rate among NSCLC patients is barely 15% (Herbst et al., 2008). Among post-surgery patients, prognosis varies widely, even...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis
Share to Thyroid Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23042802
DOI: 10.1093/jmcb/mjs050

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancerPMID 23042802Read ↗

In-depth Proteomic Analysis of Nonsmall Cell Lung Cancer to Discover Molecular Targets and Candidate BiomarkersSemantic proximity Read ↗

Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.Semantic proximity Read ↗

Single-cell spatial proteomics of non-relapse small cell lung cancer identifies tumor microenvironment determinants of survivalSemantic proximity Read ↗

Serum Monitoring and Phenotype Identification of Stage I Non-Small Cell Lung Cancer Patients.Semantic proximity Read ↗

Prediction of Recurrence-Free Survival in Postoperative Non–Small Cell Lung Cancer Patients by Using an Integrated Model of Clinical Information and Gene ExpressionSemantic proximity Read ↗

Blood-Based Gene Expression Signatures in Non–Small Cell Lung CancerSemantic proximity Read ↗

Response and toxicity prediction by MALDI-TOF-MS serum peptide profiling in patients with non-small cell lung cancer.Semantic proximity Read ↗

In‐depth proteomic analysis reveals unique subtype‐specific signatures in human small‐cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.